Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Pigment Epithelium Detachment - a Prospective Clinical Study. PED-study.

Authors not listed

Norwegian University of Science and Technology · 2014

Abstract

The purpose of this study is to determine treatment effects in patients with retinal pigment epithelium detachment (PED) in relation to Age Related Maculopathy (AMD). Patients with newly diagnosed PED without choroidal neovascularisations (CNV), will be randomized to either treatment or observation. The treatment group will first be given injections with anti Vascular Endothelium Growth Factor (anti-VEGF). If the injections do not have any effect, Verteporfin Photodynamic Therapy (PDT) will be given. All patients will be followed for a period of 2 years. It is hypothesized that treatment stops the progression of the disease and stabilizes the vision in this subgroup of patients with AMD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2014). Pigment Epithelium Detachment - a Prospective Clinical Study. PED-study. <em>Norwegian University of Science and Technology</em>. https://clinicaltrials.gov/study/NCT01746875
Vancouver
Anonymous. Pigment Epithelium Detachment - a Prospective Clinical Study. PED-study. Norwegian University of Science and Technology. 2014.
BibTeX
@misc{anon2014Pigmen, title = {Pigment Epithelium Detachment - a Prospective Clinical Study. PED-study.}, author = {Anonymous}, journal = {Norwegian University of Science and Technology}, year = {2014}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings